Advances in imaging may help gather more datasets on tumor development from a single experiment.
Software helps expedite access to dermatology appointments.
Frozen primary tumor samples will allow researchers to track lesions as they evolve and better understand the characteristics and biomarkers that distinguish aggressive melanomas.
There is room for improvement in dermatology palliative care; training can help providers raise that standard.
Sunscreen use is on the rise, but further education is needed.
Specifying histologic subtypes can drive better outcomes for patients and improve research.
Zoe Diana Draelos, MD, gives the details on sun protective clothing, including how it doesn't need to break the bank, how to test how protective clothing is, and a hat might be the most important piece of sun protection.
Scientists from Mount Sinai have reported that a mutation of the ARID2 gene may be a key factor in the risk of melanoma turning metastatic.
Merck announced that pembrolizumab led to significant improvement in distant metastasis-free survival (DMFS) compared to placebo as adjuvant therapy for patients with resected stage IIB and IIC melanoma in the phase 3 KEYNOTE-716 trial.
Skin cancer dermoscopy is getting a hightech overhaul as the scope of innovation broadens from a singular focus on the stand-alone product to the development of a comprehensive medical, patient care, and workflow management platform.